Tag: Ugur Sahin
Biontech decides billion dollar deal for new cancer drugs
Biontech Just two weeks after the multi-million dollar deal with the US cancer specialist OncoC4, the Mainz-based company agreed on another partnership. (Photo: dpa) Frankfurt Biontech is stepping on the…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Covid sales will fall sharply, continued focus on research
Frankfurt After two record years, Mainz-based Biontech SE is heading for significantly lower revenues in the Covid vaccine business. Irrespective of this, the biotech company intends to continue to massively…
Biontech secures new cancer drug with deal worth millions
Biontech founder Ugur Sahin The company is currently also growing through acquisitions. (Photo: imago images/photothek) Frankfurt With one of its largest deals to date, Biontech is expanding its product development…
Biontech and Moderna in the expansion race
Frankfurt Your sales in the Covid business will fall significantly in the current year. In research, however, Moderna and Biontech are continuing to expand at high speed. This was made…
Biontech founders’ cancer drug convinces in study
Ugur Sahin and Özlem Türeci 2018 Before Biontech, Sahin and Türeci founded the Mainz-based biotech company Ganymed. Here they researched a gastric cancer drug whose effectiveness could be proven in…
Biontech continues to expand cancer research with vaccine billions
Frankfurt The Mainz-based biotech company Biontech uses the financial strength from the still strong business with Covid vaccines to further expand its cancer and vaccine research. The quarterly figures presented…
Ema recommends approval of the Biontech/Pfizer and Moderna omicron boosters
Frankfurt A committee of experts from the European medicines agency Ema recommended on Thursday the approval of the Omikron booster vaccinations from Biontech/Pfizer and Moderna in Europe. The official approval…
When will the new corona vaccines come out?
The prospect of approval of this vaccine should significantly increase the number of vaccinations again. The vaccination campaign in Germany has been progressing slowly for months. Also because many Germans…
When will the new corona vaccines come out?
The prospect of approval of this vaccine should significantly increase the number of vaccinations again. The vaccination campaign in Germany has been progressing slowly for months. Also because many Germans…
Biontech expects rapid delivery of booster vaccines
Coronavirus Vaccination Biontech is currently submitting the last documents to the EMA. (Photo: dpa) Dusseldorf Biontech expects its corona variant vaccine to be approved in the coming week and then…
Luck in the oligopoly: one pays, one collects
In November 2023 there is a special anniversary in Germany: 50 years earlier, the government issued a driving ban due to the oil crisis and a delivery stop by Opec,…
The new magic bullet against cancer
Monday 13 June 2022 Log in subscription Newsletter podcast Club e-paper archive Shop jobs Inside my news Home politics Germany Economy International Economic Education company Industry energy Trade + consumer…
Biontech triples sales & profit in the first quarter
Biontech Because vaccine deliveries only got going in the course of 2021, Biontech can show enormous growth when compared to the previous year’s figures. (Photo: dpa) Frankfurt Thanks to extensive…
Omicron Booster: Pharmaceutical companies are working on booster vaccinations
Corona vaccine The pharmaceutical companies are already working on another booster vaccination. (Photo: IMAGO/Addictive Stock) Frankfurt According to experts, while the omicron wave is gradually peaking and many countries are…
Record profit for Biontech – special dividend for investors
Biontech founders Ugur Sahin and Özlem Türeci Frankfurt The Mainz biotech climber Biontech closed the year 2021 with a turnover of 19 billion euros and a record profit of almost…
Biontech develops AI system for early detection
Ugur Sahin The Biontech co-founder and boss has high expectations of the new technology for corona analysis. (Photo: Reuters) Frankfurt With an AI-based early warning system, the Mainz company Biontech…
Biontech and Pfizer expand vaccine alliance
Vaccine from Biontech and Pfizer The first clinical studies for the new vaccine are scheduled to start in the second half of the year. (Photo: Reuters) Frankfurt After the huge…
Wie Deutschland das Tech-Potenzial von Migrantenkindern vergeudet
Berlin Wenn Iskender Dirik sich bei seiner Arbeit als Tech-Manager und Investor über eine E-Mail ärgert oder ihn ein Meeting stresst, wandert sein Blick oft hinüber zu der Chipstüte auf…
Özlem Türeci & Ugur Sahin: Getting to the vaccine at the speed of light
Özlem Türeci and Uğur Şahin The 54-year-old Sahin is CEO and co-founder of Biontech, and his wife, who is one year younger than him, works there as Chief Medical Officer.…